Evidence map›Paper›PMID 32775605›Full record

ArticleInternational journal of cardiology. Heart & vasculature2020

Cardiovascular disease trends in Nepal - An analysis of global burden of disease data 2017.

Sanju Bhattarai, Anu Aryal, Manita Pyakurel, Swornim Bajracharya, Phanindra Baral, David Citrin, Helen Cox, Meghnath Dhimal, Annette Fitzpatrick, Anjani Kumar Jha and 12 more

Registry-linked trialAbstract read
In one paragraph

Article in International journal of cardiology. Heart & vasculature, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05794399 (Comparison of Warfarin Versus Rivaroxaban in Management of Post-myocardial Infarction Left Ventricular Thrombus in a Tertiary Cardiac Center of Nepal), which is not on this map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05794399 phase4recruitingnot on this mapstarted 2023, after this paper: background citation

Comparison of Warfarin Versus Rivaroxaban in Management of Post-myocardial Infarction Left Ventricular Thrombus in a Tertiary Cardiac Center of Nepal: a Randomized Control Study.

TypeinterventionalSponsorShahid Gangalal National Heart CentreRan2023 to 2026Enrolled196ConditionsLeft Ventricular Thrombus, Myocardial InfarctionArmsRivaroxaban, Warfarin
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Burden of coronary heart disease in Nepal: current status.The British journal of cardiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Sanju BhattaraiDepartment of Community Programs, Dhulikhel Hospital Kathmandu University Hospital, Dhulikhel, Nepal.
Anu AryalDepartment of Community Programs, Dhulikhel Hospital Kathmandu University Hospital, Dhulikhel, Nepal.
Manita PyakurelDepartment of Community Programs, Dhulikhel Hospital Kathmandu University Hospital, Dhulikhel, Nepal.
Swornim BajracharyaDepartment of Community Programs, Dhulikhel Hospital Kathmandu University Hospital, Dhulikhel, Nepal.
Phanindra BaralNon Communicable Diseases and Mental Health Section, Epidemiology and Disease Control Division, Department of Health Services, Ministry of Health and Population, Government of Nepal, Nepal.
David CitrinNyaya Health Nepal, Kathmandu, Nepal.
Helen CoxCenter for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
Meghnath DhimalNepal Health Research Council, Kathmandu, Nepal.
Annette FitzpatrickDepartments of Family Medicine, Epidemiology, and Global Health, University of Washington, Seattle, USA.
Anjani Kumar JhaNepal Health Research Council, Kathmandu, Nepal.
Niharika JhaDepartment of Community Programs, Dhulikhel Hospital Kathmandu University Hospital, Dhulikhel, Nepal.
Biraj Man KarmacharyaDepartment of Community Programs, Dhulikhel Hospital Kathmandu University Hospital, Dhulikhel, Nepal.
Rajendra KojuDepartment of Medicine (Cardiology), Dhulikhel Hospital Kathmandu University Hospital, Dhulikhel, Nepal.
Rashmi MaharjanDepartment of Community Programs, Dhulikhel Hospital Kathmandu University Hospital, Dhulikhel, Nepal.
Natalia OliDepartment of Community Medicine, Kathmandu Medical College and Teaching Hospital, Kathmandu, Nepal.
Prajjwal PyakurelSchool of Public Health and Community Medicine, B.P. Koirala Institute of Health Sciences, Dharan, Nepal.
Bhim Prasad SapkotaMinistry of Health and Population, Government of Nepal, Nepal.
Rajeev ShresthaDepartment of Pharmacology, Kathmandu University School of Medical Sciences.
Soniya ShresthaDepartment of Community Programs, Dhulikhel Hospital Kathmandu University Hospital, Dhulikhel, Nepal.
Donna SpiegelmanCenter for Methods in Implementation and Preventive Science and Department of Biostatistics, Yale School of Public Health, New Haven, USA.
Abhinav VaidyaDepartment of Community Medicine, Kathmandu Medical College and Teaching Hospital, Kathmandu, Nepal.
Archana ShresthaDepartment of Community Programs, Dhulikhel Hospital Kathmandu University Hospital, Dhulikhel, Nepal.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

Cardiovascular diseases (CVDs) are the leading cause of disease burden globally, disproportionately affecting low and middle-income countries. The continued scarcity of literature on CVDs burden in Nepal has thwarted efforts to develop population-specific prevention and management strategies. This article reports the burden of CVDs in Nepal including, prevalence, incidence, and disability basis as well as trends over the past two decades by age and gender. We used the Institute of Health Metrics and Evaluation's Global Burden of Diseases database on cardiovascular disease from Nepal to describe the most recent data available (2017) and trends by age, gender and year from 1990 to 2017. Data are presented as percentages or as rates per 100,000 population. In 2017, CVDs contributed to 26·9% of total deaths and 12·8% of total DALYs in Nepal. Ischemic heart disease was the predominant CVDs, contributing 16·4% to total deaths and 7·5% to total DALYs. Cardiovascular disease incidence and mortality rates have increased from 1990 to 2017, with the burden greater among males and among older age groups. The leading risk factors for CVDs were determined to be high systolic blood pressure, high low density lipoprotein cholesterol, smoking, air pollution, a diet low in whole grains, and a diet low in fruit. CVDs are a major public health problem in Nepal contributing to the high DALYs with unacceptable numbers of premature deaths. There is an urgent need to address the increasing burden of CVDs and their associated risk factors, particularly high blood pressure, body mass index and unhealthy diet.

Indexed as

Cardiovascular diseaseHealth systemIncidenceMortalityNepalPrevalence

Identifiers

PMID32775605
PMCPMC7399110

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.